Ankylosing spondylitis trials in Portugal

2 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 4Taking people
  An open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment

  Where

  Lisbon

  People

  339 worldwide

  Run by

  Novartis Pharma AG

  See details and how to joinNCT04638647 · EU 2023-504417-67-00
• No phaseTaking people
  Biomarkers in Inflammatory Rheumatic Diseases Diagnosis

  Where

  Lisbon

  Age

  18 years to 65 years

  People

  134

  Run by

  Universidade Nova de Lisboa

  See details and how to joinNCT06778343